226 related articles for article (PubMed ID: 35780451)
1. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma.
Wang L; Dong H; Ni S; Huang D; Tan C; Chang B; Sheng W
Oncotarget; 2016 Oct; 7(43):69749-69759. PubMed ID: 27626174
[TBL] [Abstract][Full Text] [Related]
5. Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection.
Tsai JH; Liau JY; Lee CH; Jeng YM
Am J Surg Pathol; 2021 Oct; 45(10):1409-1418. PubMed ID: 33859071
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China.
Sun K; Xu S; Wei J; Wang B; Owusu-Ansah KG; Wang W; Wu J; Zheng S
Medicine (Baltimore); 2016 Oct; 95(40):e5069. PubMed ID: 27749575
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.
Chan AW; Tong JH; Sung MY; Lai PB; To KF
Histopathology; 2014 Nov; 65(5):674-83. PubMed ID: 24804938
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
[TBL] [Abstract][Full Text] [Related]
9. Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses.
Xia T; Li K; Niu N; Shao Y; Ding D; Thomas DL; Jing H; Fujiwara K; Hu H; Osipov A; Yuan C; Wolfgang CL; Thompson ED; Anders RA; He J; Mou Y; Murphy AG; Zheng L
J Hematol Oncol; 2022 Mar; 15(1):37. PubMed ID: 35346322
[TBL] [Abstract][Full Text] [Related]
10. Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review.
Sam Saji A; Yang B; Hou WT; Liu X; Ren QP; Wei YF; Zhang YZ; Yang X
Front Oncol; 2023; 13():1090580. PubMed ID: 36865802
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein-Barr virus: Two cases report.
Ling W; Lu C; Huang H; Qiu T; Lu Q; Huang C; Gong P; Luo Y; Chen S
Medicine (Baltimore); 2019 Jan; 98(3):e14206. PubMed ID: 30653176
[TBL] [Abstract][Full Text] [Related]
12. Epstein
Peng L; Peng X; Duan S; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):319-330. PubMed ID: 38755729
[TBL] [Abstract][Full Text] [Related]
13. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F
Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068
[TBL] [Abstract][Full Text] [Related]
14. PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review.
Liao CX; Deng CS; Liang X; Yang JC; Chen ZZ; Lin XY; Lin CF; Chen S; Wu SS
Front Immunol; 2023; 14():1239168. PubMed ID: 37753076
[TBL] [Abstract][Full Text] [Related]
15. Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablation.
Nogami A; Saito S; Hasegawa H; Yoneda M; Harada K; Fujikawa H
Clin J Gastroenterol; 2021 Apr; 14(2):638-644. PubMed ID: 33400192
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract][Full Text] [Related]
17. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor.
Jeng YM; Chen CL; Hsu HC
Am J Surg Pathol; 2001 Apr; 25(4):516-20. PubMed ID: 11257627
[TBL] [Abstract][Full Text] [Related]
18. An EBV+ lymphoepithelioma-like cholangiocarcinoma in a young woman with chronic hepatitis B.
Gearty SV; Al Jurdi A; Pittman ME; Gupta R
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31289161
[TBL] [Abstract][Full Text] [Related]
19. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
20. The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
Yang Q; Cai Q; Wen H; Mao Y; Ban X; Rong D; Zhang R
AJR Am J Roentgenol; 2021 Feb; 216(2):393-402. PubMed ID: 33325732
[No Abstract] [Full Text] [Related]
[Next] [New Search]